TipRanks
Bristol-Myers Squibb (MX:BMY)
:BMY
Mexico Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BMY) Stock News & Sentiment

0 Followers
Anthropic Builds San Francisco Biology Lab to Advance AI Drug Development
Premium
Market News
Anthropic Builds San Francisco Biology Lab to Advance AI Drug Development
1d ago
BMY
NVO
Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?
Premium
Market News
Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?
1d ago
AZN
BMY
Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock
Premium
Weekend Updates
Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock
7d ago
ZM
BMY
BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod
Premium
Company Announcements
BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod
9d ago
BMY
Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors
Premium
Company Announcements
Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors
9d ago
BMY
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
Premium
Company Announcements
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
9d ago
BMY
Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial
Premium
Company Announcements
Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial
15d ago
BMY
More MX:BMY News >

BMY News on the Web

Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
Zacks
Neutral
Bristol Myers price target raised to $82 from $75 at Piper Sandler
TipRanks News
Bullish
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
The Motley Fool
Bullish
Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock
TipRanks News
Neutral
RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
TipRanks News
Neutral
Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale
TipRanks News
Bullish
Bristol-Myers Squibb Co (BMY) Insider Sale: EVP, Chief Medical Officer, Head of Development ...
GuruFocus News
Neutral
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook?
Zacks
Neutral

News Score - Last 7 Days

Positive
MX:BMY
Sector Average
Media Buzz
This Week22 articles
Weekly Average19 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:BMY’s Media Buzz Sentiment?
22 articles about MX:BMY were published this week. In an average week, 19 articles are published.
    What is MX:BMY’s weekly average amount of articles?
    In an average week, 19 articles about MX:BMY are published.
      What is MX:BMY’s News Sentiment?
      100% of articles about MX:BMY were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        ASNDAscendis Pharma
        CRBPCorbus Pharmaceuticals
        RVMDRevolution Medicines
        BNTCBenitec Biopharma
        GNNSFGenscript Biotech
        Showing the stocks with the most bullish news sentiment over the past week